We are live on ! Find out more
Q

QVR Portfolio holdings

AUM $2.49B
1-Year Est. Return 48.58%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+48.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$423M
AUM Growth
-$1.11B
Cap. Flow
+$57.9M
Cap. Flow %
13.68%
Top 10 Hldgs %
99.94%
Holding
312
New
1
Increased
Reduced
13
Closed
298

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$106M

Sector Composition

Rank Sector Weight
1 Miscellaneous 99.81%
2 Healthcare 0.09%
3 Financials 0.06%
4 Technology 0.04%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$81B
$222M 52.54%
1,000,000
-1,114,400
-53% -$252M
SPY icon
2
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$110M 25.98%
+231,591
New +$106M
QQQ icon
3
PUT
Invesco QQQ Trust
QQQ
$488B
$87.5M 20.67%
220,000
-449,000
-67% -$173M
BAC icon
4
PUT
Bank of America
BAC
$441B
$1.5M 0.36%
33,800
-109,700
-76% -$5M
ACN icon
5
PUT
Accenture
ACN
$118B
$663K 0.16%
1,600
-6,600
-80% -$2.41M
GILD icon
6
Gilead Sciences
GILD
$188B
$229K 0.05%
3,157
-286
-8% -$19.7K
PFE icon
7
PUT
Pfizer
PFE
$164B
$212K 0.05%
3,600
-73,300
-95% -$3.63M
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.09T
$208K 0.05%
696
-8,430
-92% -$2.41M
BLK icon
9
PUT
Blackrock
BLK
$174B
$183K 0.04%
200
-1,500
-88% -$1.37M
ACN icon
10
Accenture
ACN
$118B
$170K 0.04%
410
-947
-70% -$345K
PFE icon
11
Pfizer
PFE
$164B
$158K 0.04%
2,671
-4,974
-65% -$246K
BLK icon
12
Blackrock
BLK
$174B
$35K 0.01%
38
-155
-80% -$141K
PFE icon
13
CALL
Pfizer
PFE
$164B
$35K 0.01%
600
-73,500
-99% -$3.64M
GILD icon
14
CALL
Gilead Sciences
GILD
$188B
$7K ﹤0.01%
100
-20,500
-100% -$1.41M
AAPL icon
15
CALL
Apple
AAPL
$4.79T
-180,000
Closed -$25.5M
AAPL icon
16
Apple
AAPL
$4.79T
-22,977
Closed -$3.25M
AAPL icon
17
PUT
Apple
AAPL
$4.79T
-235,800
Closed -$33.4M
ABBV icon
18
CALL
AbbVie
ABBV
$460B
-16,900
Closed -$1.82M
ABBV icon
19
AbbVie
ABBV
$460B
-3,599
Closed -$388K
ABBV icon
20
PUT
AbbVie
ABBV
$460B
-36,200
Closed -$3.9M
ABT icon
21
CALL
Abbott
ABT
$188B
-21,800
Closed -$2.58M
ABT icon
22
Abbott
ABT
$188B
-6,859
Closed -$810K
ABT icon
23
PUT
Abbott
ABT
$188B
-32,500
Closed -$3.84M
ACN icon
24
CALL
Accenture
ACN
$118B
-7,000
Closed -$2.24M
ADBE icon
25
CALL
Adobe
ADBE
$114B
-5,100
Closed -$2.94M

Similar funds

QVR's Q4 2021 Portfolio in Review

As of Q4 2021, QVR held 312 positions worth $423M, down 72% from $1.53B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

QVR deployed $57.9M of net new capital in Q4 2021, opening 1 new position. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 231,591 shares worth $110M.

By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, up from 97% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $2.41M trimmed.

  • QVR's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 231,591 shares worth $110M.
  • QVR's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $2.41M.
  • QVR fully exited Microsoft in Q4 2021, selling an estimated $6.63M.
  • QVR's ten largest holdings make up 100% of its $423M portfolio in Q4 2021.
  • QVR opened 1 new position and closed 298 in Q4 2021.
  • QVR's portfolio value fell 72% quarter-over-quarter to $423M.

Based on QVR's 13F filing for Q4 2021, filed 31 Jan 2022.